Rankings
▼
Calendar
MYGN FY 2021 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena
MYGN
Myriad Genetics, Inc.
$487M
FY 2021 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$691M
+24.0% YoY
Gross Profit
$493M
71.4% margin
Operating Income
-$191M
-27.6% margin
Net Income
-$27M
-3.9% margin
EPS (Diluted)
$-0.35
Cash Flow
Operating Cash Flow
$19M
Free Cash Flow
$600,000
Stock-Based Comp.
$36M
Balance Sheet
Total Assets
$1.3B
Total Liabilities
$353M
Stockholders' Equity
$968M
Cash & Equivalents
$258M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$691M
$557M
+24.0%
Gross Profit
$493M
$379M
+30.1%
Operating Income
-$191M
-$195M
+2.2%
Net Income
-$27M
-$224M
+87.8%
← Q4 2020
All Quarters
Q1 2021 →